Historically, Autodesk has served three industries:
- Architecture, Engineering, and Construction (AEC)
- Media & Entertainment
By serving these industries, I mean we deliver technologies that enable the future of making things, whether that be a building, mechanical part, or the latest blockbuster movie. In the process, we are leading the shift in the industries we serve to cloud-based technologies and business models. As part of serving those industries, we have developed a "large model viewing" technology that is associated with our cloud offerings. It is normally used for buildings and mechanical parts. We now have a technology preview on Autodesk Labs where we leverage that viewing technology for a different industry. To quote Steve Martin, "Hey, let's get small."
3D visualization of large and multi-scale biological data, from macro-molecular structures to whole organisms, is integral to building predictive models for biomedical research; however, existing industry standard desktop, plug-in, and web-based applications can easily push beyond the limits of advanced processing and rendering.
The Autodesk Research Molecule Viewer and its visualization platform are designed to leverage cloud capabilities to overcome limitations of scalability, capability, accessibility, collaboration, and outreach for biological datasets. Layered on an extensible web-based visualization framework optimized for large 3D models and data, the Molecule Viewer streams in and visualizes translated data from the RCSB Protein Data Bank directly in the browser.
Autodesk Senior Research Scientist, Merry Wang, is the champion behind the technology preview from our Bio/nano group in the Office of the CTO.
We are eager to hear from scientists regarding what our technology brings to the table. You can reach us at [email protected] or in the forum dedicated to this technology preview on the Autodesk Labs site.
Molecular visualization is still alive in the lab.